Clinical trial
Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes
NCT00131755 is registered in ClinicalTrials.gov with Grill, Valdemar, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes
- Lead sponsor
- Grill, Valdemar, M.D.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- August 31, 2008
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.